Fiasp Vial

Fiasp (faster-acting insulin aspart) is a rapid-acting insulin designed to help manage blood sugar levels in individuals with diabetes. It starts working quickly, making it suitable for mealtime insulin therapy. Fiasp is available in vials for use with syringes or insulin pumps.

Benefits:

• Rapid onset of action helps control post-meal blood sugar spikes
• Flexible dosing options for individualized diabetes management
• Provides better blood sugar control when combined with long-acting insulin
• Approved for use in both type 1 and type 2 diabetes

Dosage:

• Administer Fiasp at the beginning of a meal or within 20 minutes after starting to eat
• Typical starting dose depends on individual needs, blood sugar levels, and medical guidance
• Adjustments may be needed based on blood sugar monitoring, meal size, and activity level
• Dosage for insulin pumps should be determined by a healthcare provider

Usage Instructions:

• Use Fiasp exactly as prescribed by your healthcare provider
• Administer subcutaneously in the abdomen, thigh, or upper arm, rotating injection sites to prevent irritation
• Inspect the vial before use; the solution should be clear and colorless
• Use a sterile insulin syringe or compatible insulin pump for administration
• Do not mix Fiasp with other insulins in the same syringe

Storage Information:

• Store unopened vials in the refrigerator at 36°F to 46°F (2°C to 8°C)
• Once opened, store the vial at room temperature (below 86°F or 30°C) for up to 28 days
• Protect from direct heat, light, and freezing

Warnings and Precautions:

• Monitor for signs of hypoglycemia, such as dizziness, sweating, or confusion
• Do not use if you are allergic to insulin aspart or any other ingredients in Fiasp
• Inform your doctor if you experience frequent low blood sugar episodes
• Be cautious when changing insulin types or dosages, as it may require medical supervision
• Avoid use in insulin pumps that are incompatible with Fiasp

Common Side Effects:

• Hypoglycemia (low blood sugar)
• Injection site reactions, such as redness or swelling
• Weight gain in some individuals
• Headache or flu-like symptoms

More information about Fisap:

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide